Influenza Pipeline — VivoSeq

Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of the Safety and Efficacy of BPL-1357 Against H1N1 Influenza Virus Challenge

Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT07215858·129 enrolled

A Double-Blinded, Randomized Influenza Virus Challenge Trial of Recombinant Influenza RG-A/Arkansas/08/2020 (pH1N1) in Healthy Adults to Assess Safety and Optimal Infectious Dose

Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT07110532·90 enrolled

A Phase 1/2, Parallel, Observer-blind Study to Assess the Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Recruiting· Sanofi logo

Sanofi·Preclinical·NCT07779408·640 enrolled

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT04772170·1,000 enrolled

Dime La VerDAD: Verify, Debunk, and Disseminate

Recruiting·UUniversity of Chicago·Preclinical·NCT06417762·1,400 enrolled

Respiratory Virus Sampling and Repository

Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT05266222·20,000 enrolled

Relative Vaccine Effectiveness of Adjuvanted Inactivated Influenza Vaccine (aIIV) vs High-Dose Inactivated Influenza Vaccine (HD-IIV) for Prevention of Lab-Confirmed Influenza Among Adults ≥65 Years of Age in the United States

Recruiting·—·N/A·NCT06029933·1,500,000 enrolled

Surveillance, Assessment and Detection of Influenza-Associated Respiratory Infections in HIV-Positive and HIV-Negative Individuals in Lusaka, Zambia

Recruiting·CCentre for Infectious Disease Research in Zambia·N/A·NCT07030075·594 enrolled

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.

Recruiting·RRuijin Hospital·Phase 3·NCT07229547·150 enrolled

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Recruiting· Roche logo

Roche·Phase 3·NCT06094010·750 enrolled

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study

Recruiting·TThe University of Hong Kong·Phase 4·NCT07240922·600 enrolled

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT05947071·312 enrolled

Intradermal Influenza Vaccination

Recruiting·YYale University·Phase 1·NCT06067555·249 enrolled

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

Recruiting·VValenta Pharm JSC·Phase 2·NCT07420985·300 enrolled

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Recruiting·UUniversity of Oxford·Phase 2·NCT05648448·3,000 enrolled

Influenza

Pipeline Metrics

Competitive Landscape

Top Companies

Programs by Phase

Modality Breakdown

Trial Status

Trial Activity